Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immatics (IMTX) Other Accumulated Expenses (2019 - 2025)

Historic Other Accumulated Expenses for Immatics (IMTX) over the last 7 years, with Q3 2025 value amounting to $5.4 million.

  • Immatics' Other Accumulated Expenses fell 6771.03% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 6771.03%. This contributed to the annual value of $7.4 million for FY2024, which is 2716.19% down from last year.
  • Per Immatics' latest filing, its Other Accumulated Expenses stood at $5.4 million for Q3 2025, which was down 6771.03% from $7.7 million recorded in Q2 2025.
  • Immatics' Other Accumulated Expenses' 5-year high stood at $16.6 million during Q3 2024, with a 5-year trough of $1.7 million in Q1 2021.
  • Its 5-year average for Other Accumulated Expenses is $6.7 million, with a median of $7.3 million in 2024.
  • As far as peak fluctuations go, Immatics' Other Accumulated Expenses plummeted by 8537.61% in 2021, and later soared by 37739.54% in 2023.
  • Quarter analysis of 5 years shows Immatics' Other Accumulated Expenses stood at $2.9 million in 2021, then surged by 227.31% to $9.6 million in 2022, then grew by 5.26% to $10.1 million in 2023, then dropped by 27.7% to $7.3 million in 2024, then decreased by 26.1% to $5.4 million in 2025.
  • Its last three reported values are $5.4 million in Q3 2025, $7.7 million for Q2 2025, and $7.0 million during Q1 2025.